Disclaimer: The information, documents and graphic depictions (the "Information") published on this Web site are the property of LIfT BioSciences Ltd. LIfT BioSciences assumes no responsibility for errors or omissions in the Information on this website. In no event shall LIfT BioSciences be liable for any special, direct, indirect, consequential, or incidental damages or any damages whatsoever, whether in an action of contract, negligence or other tort, arising out of or in connection with the use of this Web site or the Information. LIfT BioSciences reserves the right to make additions, deletions, or modification to the Information on the Web site at any time without prior notice.

  • CEO's Linked-in
  • CEO's Twitter
  • LIfTBio on Facebook

©2016 LIfT BioSciences Ltd

Please reload

Recent Posts

LIfT BioSciences Wins the Support of The European Institute for Innovation & Technology

February 12, 2019

1/7
Please reload

Featured Posts

LIfT BioSciences Wins Medcity Award

March 23, 2017

LIfT BioSciences has been announced as one of the winners of Medcity’s Collaborate to Innovate Award and grant.

 

The focus for the project work with Professor Farzin Farzaneh, Professor of Molecular Medicine at King’s College London, is to develop in-vitro evidence that LIfT BioSciences scalable cell therapy works selectively for killing pancreatic cancer cells. The patented platform could have major implications for the future treatment of all solid tumours.

 

The £2m Medcity Programme, led by King’s College London and part-funded by ERDF and HEFCE, is connecting the most promising life science SMEs with leading academics to help them develop and commercialise their technologies.

 

Sarah Haywood, CEO of MedCity said:

“London and the South East has a strong life sciences ecosystem of innovative companies developing the next generation of therapeutic and healthcare products. We have everything from new

 

drugs, development of healthcare services based on AI and VR technologies, new devices and smartphones used to help people manage their care.

Sometimes you just need a helping hand with finding a key piece of the puzzle, to get the idea from mind to market. I’m excited that we have been able to match these ground-breaking SMEs with academics from our leading universities to develop their innovations…”

 

Alex Blyth, CEO of LIfT BioSciences said

“We are delighted to be win the Medcity award and grant and have the  positive endorsement of these important institutions for the work we are doing to ultimately save patients from this horrific ‘death-sentence disease’. This win brings us one step closer to making a real difference”.  

Share on Facebook
Share on Twitter
Please reload

Follow Us

I'm busy working on my blog posts. Watch this space!

Please reload

Search By Tags